Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 616

Similar articles for PubMed (Select 11313285)

1.

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, Ferrara JL, Burakoff SJ, van den Brink MR.

Blood. 2001 May 1;97(9):2886-95.

3.

T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms.

Hsieh MH, Patterson AE, Korngold R.

Biol Blood Marrow Transplant. 2000;6(3):231-40.

PMID:
10871148
9.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
12.

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation.

Reddy P, Teshima T, Hildebrandt G, Duffner U, Maeda Y, Cooke KR, Ferrara JL.

Blood. 2002 Nov 1;100(9):3429-31.

14.

Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.

Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H, Jain D, McNiff J, Shlomchik WD.

Blood. 2008 Feb 15;111(4):2476-84. Epub 2007 Nov 28.

15.

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.

J Clin Invest. 1999 Aug;104(3):317-25.

16.

Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, Ferrara JL.

Blood. 2005 Mar 1;105(5):2023-7. Epub 2004 Oct 5.

17.
18.

Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.

Imado T, Iwasaki T, Kuroiwa T, Sano H, Hara H.

Transplantation. 2004 Feb 15;77(3):391-8.

PMID:
14966413
19.

Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.

Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE.

J Immunol. 1996 Dec 1;157(11):4811-21.

PMID:
8943383
20.

Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.

van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Murphy GF, Burakoff SJ.

Transplantation. 2000 Jul 15;70(1):184-91.

PMID:
10919598
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk